Type 1 Edition Junior

Clinical Summary

Toujeo Logo

Type 1 Edition Junior Clinical Summary

A summary of the Edition Junior study which is 6-month, randomised, open-label, double-arm, parallel-group, non-inferiority study in 463 paediatric patients with T1DM. This is the only paediatric trial comparing a second-generation insulin – Toujeo® vs Lantus® (insulin glargine 100 units/mL).

Woman on the telephone

Always up to date?

Webinars, evidence, expert videos, peer-to-peer events… Do you want to be the first to know when new, relevant information is available? Let us know and we’ll send you a message.

MAT-IE-2001763 (v6.0)
Date of preparation: January 2024